A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients
BLZ-100(托祖勒斯汀)的首次人体研究证实了其在皮肤癌患者中的耐受性和安全性。
期刊:Contemporary Clinical Trials Communications
影响因子:1.4
doi:10.1016/j.conctc.2021.100830
Yamada, Miko; Miller, Dennis M; Lowe, Melinda; Rowe, Casey; Wood, Dominic; Soyer, H Peter; Byrnes-Blake, Kelly; Parrish-Novak, Julia; Ishak, Laura; Olson, James M; Brandt, Gordon; Griffin, Paul; Spelman, Lynda; Prow, Tarl W